Nira Pollock, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Clostridium Infections | 16 | 2023 | 557 | 4.300 |
Why?
|
Bacterial Toxins | 13 | 2023 | 931 | 4.110 |
Why?
|
Antigens, Viral | 10 | 2024 | 980 | 2.290 |
Why?
|
Reagent Kits, Diagnostic | 7 | 2021 | 238 | 2.020 |
Why?
|
Point-of-Care Systems | 14 | 2022 | 1208 | 1.850 |
Why?
|
Feces | 12 | 2023 | 1466 | 1.850 |
Why?
|
Hemorrhagic Fever, Ebola | 5 | 2017 | 420 | 1.850 |
Why?
|
Enterotoxins | 7 | 2023 | 367 | 1.760 |
Why?
|
Mycobacterium tuberculosis | 12 | 2024 | 1905 | 1.330 |
Why?
|
Ebolavirus | 3 | 2016 | 252 | 1.280 |
Why?
|
Alanine Transaminase | 4 | 2015 | 607 | 1.220 |
Why?
|
Blood Chemical Analysis | 3 | 2015 | 437 | 1.200 |
Why?
|
Bacterial Proteins | 9 | 2022 | 3822 | 1.170 |
Why?
|
Clinical Laboratory Techniques | 4 | 2016 | 749 | 1.120 |
Why?
|
Tuberculosis | 7 | 2024 | 2003 | 1.010 |
Why?
|
Tuberculosis, Pulmonary | 7 | 2024 | 832 | 0.930 |
Why?
|
Sensitivity and Specificity | 27 | 2024 | 14656 | 0.870 |
Why?
|
RNA, Viral | 5 | 2021 | 2837 | 0.870 |
Why?
|
Asymptomatic Infections | 2 | 2021 | 131 | 0.870 |
Why?
|
Carrier State | 5 | 2021 | 525 | 0.840 |
Why?
|
Influenza A virus | 2 | 2024 | 457 | 0.780 |
Why?
|
Erythema Chronicum Migrans | 1 | 2021 | 48 | 0.770 |
Why?
|
Specimen Handling | 4 | 2021 | 708 | 0.770 |
Why?
|
Liver Function Tests | 2 | 2013 | 524 | 0.760 |
Why?
|
Immunoenzyme Techniques | 3 | 2023 | 1705 | 0.750 |
Why?
|
Pharyngitis | 1 | 2022 | 220 | 0.730 |
Why?
|
Antigens, Bacterial | 5 | 2019 | 1155 | 0.670 |
Why?
|
Tuberculin Test | 2 | 2010 | 206 | 0.640 |
Why?
|
Influenza, Human | 4 | 2024 | 1532 | 0.630 |
Why?
|
Immunoassay | 3 | 2022 | 748 | 0.630 |
Why?
|
Lyme Disease | 2 | 2021 | 630 | 0.590 |
Why?
|
Diarrhea | 4 | 2023 | 1341 | 0.580 |
Why?
|
Diagnostic Tests, Routine | 4 | 2024 | 785 | 0.560 |
Why?
|
Paper | 3 | 2015 | 85 | 0.560 |
Why?
|
Interferon-gamma | 5 | 2013 | 3160 | 0.540 |
Why?
|
Viral Load | 3 | 2024 | 3323 | 0.530 |
Why?
|
Blood Specimen Collection | 1 | 2017 | 238 | 0.530 |
Why?
|
Nucleoproteins | 1 | 2016 | 113 | 0.520 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 5 | 2015 | 3804 | 0.480 |
Why?
|
Aspartate Aminotransferases | 2 | 2013 | 415 | 0.480 |
Why?
|
DNA, Bacterial | 4 | 2024 | 1455 | 0.460 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2015 | 265 | 0.450 |
Why?
|
Health Personnel | 3 | 2013 | 3310 | 0.430 |
Why?
|
Nasopharynx | 4 | 2021 | 394 | 0.430 |
Why?
|
Lipopolysaccharides | 1 | 2019 | 2214 | 0.390 |
Why?
|
Transaminases | 1 | 2012 | 196 | 0.390 |
Why?
|
Immunologic Tests | 2 | 2024 | 103 | 0.380 |
Why?
|
Hepatitis | 1 | 2013 | 231 | 0.370 |
Why?
|
Latent Tuberculosis | 1 | 2013 | 224 | 0.360 |
Why?
|
Oropharynx | 2 | 2021 | 132 | 0.350 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2015 | 448 | 0.350 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 66 | 0.340 |
Why?
|
Developing Countries | 3 | 2018 | 2880 | 0.340 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4573 | 0.330 |
Why?
|
Humans | 75 | 2024 | 760261 | 0.320 |
Why?
|
Dictyostelium | 2 | 1999 | 70 | 0.310 |
Why?
|
Glycoproteins | 1 | 2016 | 2208 | 0.310 |
Why?
|
Mouth Mucosa | 2 | 2020 | 426 | 0.300 |
Why?
|
Isoniazid | 1 | 2009 | 283 | 0.290 |
Why?
|
Drug Monitoring | 1 | 2013 | 966 | 0.290 |
Why?
|
Child | 17 | 2023 | 79758 | 0.280 |
Why?
|
Organelles | 2 | 1999 | 267 | 0.280 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2021 | 612 | 0.260 |
Why?
|
Genetic Techniques | 2 | 2020 | 428 | 0.250 |
Why?
|
Mass Screening | 1 | 2021 | 5422 | 0.250 |
Why?
|
Proteomics | 1 | 2018 | 3810 | 0.230 |
Why?
|
Tuberculosis, Pleural | 2 | 2013 | 13 | 0.230 |
Why?
|
Radiography, Thoracic | 1 | 2010 | 1295 | 0.230 |
Why?
|
Pandemics | 4 | 2023 | 8621 | 0.220 |
Why?
|
Phlebotomy | 2 | 2015 | 137 | 0.210 |
Why?
|
Adult | 21 | 2024 | 219847 | 0.210 |
Why?
|
Pathology, Clinical | 1 | 2006 | 375 | 0.210 |
Why?
|
Antitubercular Agents | 2 | 2020 | 1374 | 0.200 |
Why?
|
Antibodies, Bacterial | 3 | 2022 | 1470 | 0.200 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2024 | 330 | 0.190 |
Why?
|
Toxemia | 1 | 2020 | 14 | 0.190 |
Why?
|
Hospitals, Pediatric | 2 | 2020 | 1853 | 0.190 |
Why?
|
Nucleocapsid | 1 | 2021 | 63 | 0.190 |
Why?
|
RNA | 3 | 2023 | 2721 | 0.180 |
Why?
|
Temperature | 2 | 2021 | 2221 | 0.180 |
Why?
|
Recurrence | 2 | 2023 | 8487 | 0.170 |
Why?
|
Borrelia burgdorferi | 1 | 2021 | 182 | 0.170 |
Why?
|
Reproducibility of Results | 7 | 2024 | 20048 | 0.170 |
Why?
|
Molecular Motor Proteins | 1 | 1999 | 105 | 0.170 |
Why?
|
Intracellular Membranes | 1 | 1999 | 389 | 0.160 |
Why?
|
Cough | 1 | 2022 | 595 | 0.160 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 220 | 0.160 |
Why?
|
Peru | 4 | 2024 | 870 | 0.150 |
Why?
|
Polymerase Chain Reaction | 2 | 2023 | 6067 | 0.150 |
Why?
|
Observer Variation | 2 | 2015 | 2596 | 0.150 |
Why?
|
South America | 1 | 2018 | 181 | 0.150 |
Why?
|
Erysipelothrix Infections | 1 | 2017 | 4 | 0.150 |
Why?
|
Plasmodium | 1 | 2020 | 247 | 0.150 |
Why?
|
Microfluidics | 2 | 2013 | 654 | 0.140 |
Why?
|
Dyneins | 1 | 1998 | 124 | 0.140 |
Why?
|
Interleukin-1beta | 1 | 2023 | 999 | 0.140 |
Why?
|
Child, Preschool | 5 | 2022 | 42034 | 0.140 |
Why?
|
Africa, Western | 1 | 2017 | 159 | 0.140 |
Why?
|
Male | 23 | 2024 | 359413 | 0.140 |
Why?
|
Reference Standards | 3 | 2021 | 1004 | 0.140 |
Why?
|
Metagenomics | 1 | 2020 | 457 | 0.140 |
Why?
|
Saliva | 1 | 2021 | 816 | 0.140 |
Why?
|
Bites and Stings | 1 | 2017 | 93 | 0.130 |
Why?
|
Asia | 1 | 2018 | 618 | 0.130 |
Why?
|
Schools | 2 | 2023 | 1474 | 0.130 |
Why?
|
Female | 23 | 2024 | 391011 | 0.130 |
Why?
|
Community Health Services | 1 | 2021 | 654 | 0.130 |
Why?
|
Amino Acid Sequence | 3 | 2018 | 13456 | 0.130 |
Why?
|
Sierra Leone | 1 | 2016 | 168 | 0.130 |
Why?
|
Oxidoreductases | 1 | 2018 | 412 | 0.130 |
Why?
|
Occupational Health | 2 | 2013 | 804 | 0.130 |
Why?
|
Africa South of the Sahara | 1 | 2018 | 743 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1618 | 0.120 |
Why?
|
Headache | 1 | 2022 | 1249 | 0.120 |
Why?
|
Fingers | 1 | 2017 | 505 | 0.120 |
Why?
|
Adolescent | 9 | 2020 | 87747 | 0.120 |
Why?
|
Arthritis, Infectious | 1 | 2017 | 345 | 0.110 |
Why?
|
Middle Aged | 16 | 2024 | 220175 | 0.110 |
Why?
|
Immunoglobulin G | 5 | 2023 | 4546 | 0.100 |
Why?
|
Vietnam | 1 | 2013 | 411 | 0.100 |
Why?
|
Chromatography, Affinity | 1 | 2013 | 534 | 0.100 |
Why?
|
Schistosomiasis | 1 | 2013 | 64 | 0.100 |
Why?
|
Infant | 4 | 2020 | 36030 | 0.100 |
Why?
|
Prospective Studies | 5 | 2023 | 54263 | 0.100 |
Why?
|
Microtubules | 1 | 1998 | 1072 | 0.100 |
Why?
|
Massachusetts | 2 | 2023 | 8805 | 0.100 |
Why?
|
Immunologic Factors | 1 | 2021 | 1589 | 0.100 |
Why?
|
Prevalence | 3 | 2023 | 15687 | 0.100 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2013 | 136 | 0.090 |
Why?
|
Aged, 80 and over | 4 | 2019 | 58947 | 0.090 |
Why?
|
Chagas Disease | 1 | 2013 | 167 | 0.090 |
Why?
|
Cluster Analysis | 1 | 2018 | 2698 | 0.090 |
Why?
|
Malaria | 1 | 2020 | 1226 | 0.090 |
Why?
|
Sputum | 2 | 2024 | 503 | 0.090 |
Why?
|
Tuberculin | 1 | 2009 | 64 | 0.080 |
Why?
|
Molecular Weight | 3 | 2008 | 2186 | 0.080 |
Why?
|
Young Adult | 5 | 2024 | 58673 | 0.080 |
Why?
|
Aged | 8 | 2024 | 168995 | 0.080 |
Why?
|
Escherichia coli Infections | 1 | 2013 | 524 | 0.080 |
Why?
|
Ornithine Carbamoyltransferase | 1 | 2008 | 27 | 0.080 |
Why?
|
Immunoglobulin A | 2 | 2023 | 978 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1759 | 0.070 |
Why?
|
Molecular Sequence Data | 3 | 2013 | 17628 | 0.070 |
Why?
|
Skin Tests | 1 | 2009 | 637 | 0.070 |
Why?
|
Nerve Tissue Proteins | 1 | 1999 | 4409 | 0.070 |
Why?
|
Costs and Cost Analysis | 1 | 2012 | 1679 | 0.070 |
Why?
|
Predictive Value of Tests | 4 | 2024 | 15273 | 0.060 |
Why?
|
World Health Organization | 2 | 2022 | 1319 | 0.060 |
Why?
|
Incidental Findings | 1 | 2010 | 698 | 0.060 |
Why?
|
Peptide Fragments | 1 | 2018 | 5120 | 0.060 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2013 | 931 | 0.060 |
Why?
|
Biological Transport | 2 | 1999 | 2087 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3466 | 0.060 |
Why?
|
Heart Transplantation | 1 | 2017 | 3217 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2020 | 26168 | 0.050 |
Why?
|
Ribotyping | 1 | 2022 | 35 | 0.050 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 2022 | 144 | 0.050 |
Why?
|
Antitoxins | 1 | 2023 | 80 | 0.050 |
Why?
|
Urinalysis | 1 | 2024 | 368 | 0.050 |
Why?
|
Escherichia coli | 1 | 2013 | 4223 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4668 | 0.040 |
Why?
|
Laxatives | 1 | 2020 | 90 | 0.040 |
Why?
|
Risk Factors | 3 | 2023 | 74269 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2020 | 80301 | 0.040 |
Why?
|
Cloning, Molecular | 2 | 2008 | 4172 | 0.040 |
Why?
|
Microscopy, Video | 1 | 1999 | 242 | 0.040 |
Why?
|
North America | 1 | 2022 | 1282 | 0.040 |
Why?
|
Germany | 1 | 2021 | 875 | 0.040 |
Why?
|
T-Lymphocytes | 2 | 2013 | 10183 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2008 | 2178 | 0.040 |
Why?
|
Lymphocyte Activation | 1 | 2009 | 5498 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 486 | 0.040 |
Why?
|
Dimerization | 1 | 1999 | 890 | 0.040 |
Why?
|
Membranes | 1 | 1998 | 165 | 0.040 |
Why?
|
Anura | 1 | 2017 | 80 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2022 | 621 | 0.040 |
Why?
|
Cohort Studies | 4 | 2023 | 41317 | 0.040 |
Why?
|
Fresh Water | 1 | 2017 | 82 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2755 | 0.030 |
Why?
|
Limit of Detection | 1 | 2015 | 280 | 0.030 |
Why?
|
Debridement | 1 | 2017 | 492 | 0.030 |
Why?
|
Liposomes | 1 | 1998 | 776 | 0.030 |
Why?
|
Students | 1 | 2023 | 1722 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17159 | 0.030 |
Why?
|
Movement | 1 | 1999 | 1474 | 0.030 |
Why?
|
Dogs | 1 | 2017 | 3843 | 0.020 |
Why?
|
Gene Deletion | 1 | 1999 | 2668 | 0.020 |
Why?
|
Kinetics | 1 | 1999 | 6378 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2012 | 1056 | 0.020 |
Why?
|
Time Factors | 1 | 2012 | 40133 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2578 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2024 | 22041 | 0.020 |
Why?
|
Pleural Effusion | 1 | 2013 | 343 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 1746 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2008 | 6543 | 0.020 |
Why?
|
Animals | 5 | 2020 | 167940 | 0.020 |
Why?
|
Preoperative Care | 1 | 2017 | 2255 | 0.020 |
Why?
|
Tuberculosis Vaccines | 1 | 2008 | 48 | 0.020 |
Why?
|
Algorithms | 1 | 2008 | 13967 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3618 | 0.020 |
Why?
|
Peptides | 1 | 1999 | 4358 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2008 | 1061 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7345 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12968 | 0.020 |
Why?
|
Cell Line | 1 | 1999 | 15626 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2008 | 814 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18415 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 2008 | 1070 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15827 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16543 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2009 | 64947 | 0.010 |
Why?
|
Rabbits | 1 | 2008 | 4773 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2008 | 2192 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12447 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5039 | 0.010 |
Why?
|
United States | 1 | 2008 | 72363 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7400 | 0.010 |
Why?
|
Acute Disease | 1 | 2008 | 7268 | 0.010 |
Why?
|
Neutrophils | 1 | 2008 | 3770 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25928 | 0.010 |
Why?
|
Mutation | 1 | 1998 | 29950 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81216 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10434 | 0.010 |
Why?
|